Ocular Therapeutix CSO Sells Small Stake to Cover Taxes After RSU Vesting
Ocular Therapeutix Chief Scientific Officer Jeffrey S. Heier sold 3,057 shares on February 23, 2026, for roughly $25,311 to satisfy tax obligations tied to vested restricted stock units. The transaction left Heier with 323,368 shares. The stock has since risen, and recent positive Phase 3 SOL-1 data for Axpaxli and divergent analyst reactions are i…